Target type: biologicalprocess
Any process that decreases the frequency, rate or extent of mesenchymal cell proliferation that contributes to the progression of the ureter gland over time. A mesenchymal cell is a cell that normally gives rise to other cells that are organized as three-dimensional masses, rather than sheets. [GOC:mtg_kidney_jan10]
The negative regulation of mesenchymal cell proliferation is a crucial step in ureter development, ensuring proper formation of the urinary tract. This process involves a complex interplay of signaling pathways, transcription factors, and extracellular matrix components.
**1. Signaling Pathways:**
- **Fibroblast Growth Factor (FGF) signaling:** FGFs, particularly FGF2 and FGF7, act as potent mitogens for mesenchymal cells during ureter development. However, negative regulation of FGF signaling is essential to restrict proliferation and promote differentiation.
- **Transforming Growth Factor-β (TGF-β) signaling:** TGF-β signaling plays a dual role in ureter development. While it can promote proliferation in early stages, it also inhibits proliferation in later stages, contributing to the formation of a mature ureter.
- **Wnt signaling:** Wnt signaling is involved in various aspects of ureter development, including branching morphogenesis and mesenchymal cell proliferation. The Wnt/β-catenin pathway can promote proliferation, but its activity is tightly regulated to prevent uncontrolled growth.
- **Bone Morphogenetic Protein (BMP) signaling:** BMPs, especially BMP4, can inhibit mesenchymal cell proliferation and promote differentiation, ensuring the formation of a well-defined ureteral tube.
**2. Transcription Factors:**
- **Pax2:** A key transcription factor crucial for ureter development. Pax2 is expressed in the ureteric bud and regulates the expression of genes involved in proliferation, differentiation, and branching morphogenesis.
- **Sox2:** Another essential transcription factor that interacts with Pax2 and plays a role in regulating mesenchymal cell proliferation and differentiation.
- **Hox genes:** Hox genes, particularly Hoxb7, are involved in patterning the ureter and regulate proliferation along the proximodistal axis.
**3. Extracellular Matrix Components:**
- **Collagen:** Collagen is a major component of the extracellular matrix, providing structural support and influencing cell behavior. During ureter development, collagen deposition helps regulate mesenchymal cell proliferation and differentiation.
- **Heparan sulfate proteoglycans (HSPGs):** HSPGs bind to growth factors and regulate their signaling activity. They play a role in fine-tuning the response of mesenchymal cells to growth factors, ensuring appropriate proliferation and differentiation.
**4. Cellular Mechanisms:**
- **Cell cycle regulation:** Negative regulation of mesenchymal cell proliferation involves controlling the progression through the cell cycle. Cyclin-dependent kinases (CDKs) and their inhibitors regulate the transition between different cell cycle phases.
- **Apoptosis:** Programmed cell death, or apoptosis, is essential for sculpting the ureter and removing excess cells. Apoptotic pathways can be activated by factors that inhibit proliferation, contributing to the overall regulation of mesenchymal cell number.
In summary, negative regulation of mesenchymal cell proliferation in ureter development is a complex and tightly regulated process involving multiple signaling pathways, transcription factors, extracellular matrix components, and cellular mechanisms. This intricate interplay ensures the formation of a properly shaped and functional ureter, essential for proper urinary tract function.'
"
Protein | Definition | Taxonomy |
---|---|---|
Bone morphogenetic protein 4 | A bone morphogenetic protein 4 that is encoded in the genome of human. [PRO:CNA, UniProtKB:P12644] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
dorsomorphin | dorsomorphin : A pyrazolopyrimidine that is pyrazolo[1,5-a]pyrimidine which is substituted at positions 3 and 6 by pyridin-4-yl and p-[2-(piperidin-1-yl)ethoxy]phenyl groups, respectively. It is a potent, selective, reversible, and ATP-competitive inhibitor of AMPK (AMP-activated protein kinase, EC 2.7.11.31) and a selective inhibitor of bone morphogenetic protein (BMP) signaling. dorsomorphin: an AMPK inhibitor | aromatic ether; piperidines; pyrazolopyrimidine; pyridines | bone morphogenetic protein receptor antagonist; EC 2.7.11.31 {[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase} inhibitor |
ldn 193189 | LDN 193189: inhibits bone morphogenetic protein signaling | pyrimidines | |
ml347 | ML347: an ALK2 inhibitor; structure in first source |